Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite ...

The weight loss injection Mounjaro is a new treatment that can now be delivered to customers' homes by a new clinic service offered by Morrisons.

Ozempic is traditionally used as a treatment for type 2 diabetes (T2DM) to help patients manage blood sugar levels. However, ...

Wegovy is the brand name for semaglutide which is licensed and approved for managing ... or heart problems Mounjaro is available as a pre-filled injection pen that is to be injected under the skin of ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

The new vials – priced at $399 and $549, respectively, for a month's supply – are a lower-cost alternative to the current injector pen formulation ... latter's Wegovy (semaglutide) brand.

The current wholesale acquisition cost (WAC) of Ozempic as of January 2025 is $998 for a one-pen set. The WAC for Victoza ... Label: Victoza- liraglutide injection. DailyMed. Label: Ozempic- ...

Eli Lilly and Company LLY reported fourth-quarter 2024 adjusted earnings per share (“EPS”) of $5.32, which beat the Zacks ...

Novo Nordisk also sells semaglutide as Ozempic for diabetes ... obesity and is currently available in the original singe-dose pen-injector format. Mounjaro has already been launched in other ...